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Polymorphism N (%)
PlA
A1/A1 82 (89.1%)
A1/A2 10 (10.9%)
Glu298asp
Glu/Glu 81 (88.0%)
Glu/Asp 11 (12.0%)
_922a_g
A/A 65 (70.7%)
A/G 22 (23.9%)
G/G 5 (5.4%)
Int
420/420 76 (82.65)
420/393 16 (17.4%)
-786T>C
TT 58 (63.0%)
CC 9 (9.8%)
TC 25 (27.25)
Table. Clinical characteristics and prevalence of stent fracture in CoCr-EES
versus ML VISION
CoCr-EES (n=70) ML VISION (n=47) p value
ACS as an indication for
stenting
33 (47%) 14 (30%) 0.06
Duration of implant (days) 174 (30 – 360) 210 (14 – 540) 0.38
Stent length (mm): Only CoCr-
EES or ML VISION
21 (15 – 29) 18 (12 – 24) 0.045
Stent length (mm): Including
different type of stents
23 (15 – 38) 20 (12 – 35) 0.25
Overlapping stents: Only CoCr-
EES or ML VISION
21 (30%) 10 (21%) 0.29
Overlapping stents: Including
different type of stents
29 (41%) 17 (36%) 0.57
Number of stent (CoCr-EES or
ML VISION) per lesion
1.5  1.1 1.3  0.6 0.12
Prevalence of stent fracture
(all)
8 (11%) 4 (8.5%) 0.61
Grade I fracture 3 (4.3%) 2 (4.3%) 0.99
Grade II fracture 1 (1.4%) 1 (2.1%) 0.77
Grade III fracture 3 (4.3%) 0 0.15
Grade IV fracture 0 0 -
Grade V fracture 1 (1.4%) 1 (2.1%) 0.77
Fracture-related adverse
events
3 restenosis (4.3%) 1 restenosis (2.1%) 0.53
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SConclusions: This study shows that the presence of PlA2 polymorphism is an
independent risk factor for coronary in-stent restenosis and a marker for need of new
revascularization. Its detection could have important implications in decision making.
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Background: Published preclinical studies demonstrated that polymer-coated stents
with thin struts exhibit less thrombogenicity as compared to uncoated or thick strut stents
(Circulation 2011;123:1400-1409); however, no pathologic studies havebeen reported in
man.We sought to evaluate the pathologic prevalence of early stent thrombosis (ST,30
days) in cobalt-chromium everolimus-eluting stent (CoCr-EES) as compared to siroli-
mus-eluting (SES), paclitaxel-eluting (PES), and bare metal stents (BMS) in humans.
Methods: A total of 102 stented coronary lesions with duration of implant 30 days
(CoCr-EES¼17, SES¼30, PES¼39, and BMS¼16 MULTI-LINK VISION [ML
VISION, Abbott Vascular, Santa Clara, CA]) from 77 autopsy cases were histo-
pathologically evaluated for the prevalence of early ST and its etiology.
Results: Clinical and pathologic characteristics including duration of implant, indica-
tions for stenting, stent length, prevalence of bifurcation multistenting, incomplete stent
apposition, and medial disruption were comparable among the groups, while the number
of stents per lesionwas greater in CoCr-EES as compared to SES (p¼0.02) (Table). Early
ST was identiﬁed in 39 of 102 lesions (39%). The prevalence of early ST was the least in
CoCr-EES (3 of 17 lesions, 18%), followed by PES (36%) and SES (43%), and was the
highest inBMS (56%, p¼0.02 vs. CoCr-EES). Etiologies of early ST in the 3 lesionswith
CoCr-EES were septic thrombi, bifurcation multistenting, and long/overlapping stenting
(stent length¼70 mm), respectively. Other etiologies for SES, PES and BMS included
medial disruption, necrotic core prolapse, strut malapposition, and stent fracture.
Conclusions: CoCr-EES had the lowest prevalence of early ST as compared to SES,
PES, and BMS in human autopsy cases, and signiﬁcant difference was identiﬁed
between CoCr-EES and BMS (ML-VISION).Table. Clinical and pathologic characteristics and prevalence of early stent
thrombosis in CoCr-EES versus SES, PES, and BMS (ML-VISION)
CoCr-EES
(n=17) SES (n=30) PES (n=39)
ML VISION
(n=16)
p value: CoCr-EES vs.
SES PES BMS
Duration of
implant
(days)
7 (1.5 – 11) 5 (1 – 7) 5 (3-7) 13 (1.3 – 20) 0.25 0.58 0.37
ACS as an
indication for
stenting
24% 50% 44% 38% 0.08 0.15 0.38
Stent length
(mm)
27 (16 – 52) 21 (18 – 35) 22 (16 – 32) 23 (14 – 41) 0.39 0.34 0.41
Bifurcation
multistenting
29% 20% 18% 6% 0.46 0.34 0.08
Number of
stents per
lesion
2.2  1.8 1.4  0.6 1.6  0.8 1.5  0.6 0.02 0.07 0.14
Incomplete
stent
apposition
12% 10% 15% 13% 0.85 0.72 0.95
Medial
disruption
47% 67% 56% 53% 0.19 0.52 0.72
Prevalence of
early ST
18% 43% 36% 56% 0.07 0.17 0.02
Values are expressed as mean  SD, median (interquartile range), or prevalence (%).
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Background: Stent fracture is associated with adverse cardiac events including
thrombosis and restenosis where the underlying mechanisms of stent fracture have
been considered to be multifactorial. It remains unknown whether drug-eluting and
bare metal stents with similar platform exhibit difference in the prevalence of stent
fracture in humans.
Methods: A total of 117 stented coronary lesions (70 cobalt chromium everolimus-
eluting stents [CoCr-EES] and 47 bare metal MULTI-LINK VISION stents [ML
VISION, Abbott Vascular, Santa Clara, CA]) from 83 autopsy cases with matched
duration of implant (3 years; median¼180 days) were analyzed. Of these, 18 (15%)
had different type of stents in the same lesion (9 [13%] in CoCr-EES and 9 [19%] in
ML VISION). Stented arteries were removed from the heart and high contrast radi-
ography was performed to determine the presence and degree of stent fracture, fol-
lowed by histologic assessment for patency, thrombosis and restenosis.
Results: There were no signiﬁcant differences in clinical indications, duration of
implant, prevalence of overlapping stents, and number of stent per lesion between the
groups, while stent length limited for each stent type was longer in CoCr-EES as
compared to ML VISION (Table). Stent fracture was identiﬁed in 8 of 70 lesions with
CoCr-EES (11%), which did not differ from ML VISION (4 of 47 lesions [8.5%],
p¼0.61). The prevalence of grade V fracture (acquired transection with gap in the
stent body) was also comparable between CoCr-EES (1.4%) and ML VISION (2.1%,
p¼0.77). Moreover, fracture-related adverse events did not differ between the groups
(CoCr-EES¼3 restenosis [4.3%] vs. ML VISION¼1 restenosis [2.1%], p¼0.53).
Conclusions: The current pathologic study with high contrast radiography assessment
showed similar prevalence of stent fracture in CoCr-EES and ML VISION in humans.Values are expressed as mean  SD, median (interquartile range), or n (%).TCT-476
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Background: A dramatic increase in reports of longitudinal stent deformation (LSD)
in the MAUDE database has recently been described. However, as a complications
database these reports may not be representative of typical cases - possibly involvingacts/POSTER/In-stent Restenosis and Stent Thrombosis B145
